Cooper Companies (The) (COO) earnings call transcript summary & sentiment
Last call Thu 4 Jun 2026
Our read on the 4 June 2026 earnings call
Overall tone: Positive
Overall tone
Positive
Executive Summary
Cooper Companies delivered record Q2 2026 revenue of $1.08 billion (+8% reported, +5% organic) and non-GAAP EPS of $1.21 (+26%), beating consensus for the 10th consecutive quarter through strong operating leverage and solid performance in fertility and daily silicone hydrogel lenses.
Core Signals
Revenue Growth & Demand: Consolidated Q2 revenue rose 8% YoY to $1.08 billion (5% organic growth), supported by 4% organic growth in CooperVision and 6% organic growth in CooperSurgical.
Bullish Signals
Settlement agreements covering over 95% of embryo media litigation claims resolve a major legal overhang for a net impact of $271.6 million.
Risk Signals
Full-year CooperVision organic growth guidance was lowered to 3.5%–4.5% due to soft market conditions in Asia-Pacific.
Q&A Signals
Repeated analyst topics: Analysts repeatedly focused on the structure, buyer profile, potential timing, and RemainCo dis-synergies associated with the CooperSurgical strategic review.
Key Investor Debate
The central debate focuses on whether divesting CooperSurgical will capture a private market valuation premium that outweighs prospective corporate dis-synergies and standalone tax friction for RemainCo.
Analyst Takeaway
Management's ability to maintain full-year EPS guidance while absorbing CooperVision top-line trims highlights strong operating cost discipline and structural margin leverage across the business.
Those are the opening lines. The full read covers the whole earnings transcript: every
bullish and bearish signal, what analysts pressed hardest on, and where management
answered vaguely — each with the quote behind it. Every line sourced.
Ask about Cooper Companies (The)'s earnings, or other S&P 500 earnings calls
Ask across the corpus, instead of reading one call at a time. Scope it to Cooper Companies (The), its
sector, or every name we cover — plain English, no operators — and answers come back
structured: a summary, the drivers, and a read on each company.
"What did Cooper Companies (The) say about margins, and did the framing change from last quarter?"
"Did Cooper Companies (The)'s management walk back any full-year guidance, and how did they frame it?"
"Where did Cooper Companies (The) avoid answering on capital allocation?"
Cooper Companies (The) is one of the S&P 500 companies we track
Sentiment analysis on any single earnings call, themes building across a sector, and search
across every company and quarter — each claim linked back to the passage it came from.